PUBLICATION

REP1 inhibits FOXO3-mediated apoptosis to promote cancer cell survival

Authors
Song, K.H., Woo, S.R., Chung, J.Y., Lee, H.J., Oh, S.J., Hong, S.O., Shim, J., Kim, Y.N., Rho, S.B., Hong, S.M., Cho, H., Hibi, M., Bae, D.J., Kim, S.Y., Kim, M.G., Kim, T.W., Bae, Y.K.
ID
ZDB-PUB-170106-2
Date
2017
Source
Cell Death & Disease   8: e2536 (Journal)
Registered Authors
Bae, Young Ki, Hibi, Masahiko
Keywords
none
MeSH Terms
  • Adaptor Proteins, Signal Transducing/biosynthesis
  • Adaptor Proteins, Signal Transducing/genetics*
  • Animals
  • Apoptosis/genetics
  • Carcinogenesis/genetics*
  • Cell Line, Tumor
  • Cell Survival/genetics
  • Choroideremia/genetics
  • Choroideremia/pathology
  • Colonic Neoplasms/genetics*
  • Colonic Neoplasms/pathology
  • Disease Models, Animal
  • Fluorouracil/administration & dosage
  • Forkhead Box Protein O3/biosynthesis
  • Forkhead Box Protein O3/genetics*
  • Gene Expression Regulation, Neoplastic/drug effects
  • Humans
  • Mice
  • Mutation
  • Xenograft Model Antitumor Assays
  • Zebrafish/genetics
PubMed
28055019 Full text @ Cell Death Dis.
Abstract
Rab escort protein 1 (REP1) is a component of Rab geranyl-geranyl transferase 2 complex. Mutations in REP1 cause a disease called choroideremia (CHM), which is an X-linked eye disease. Although it is postulated that REP1 has functions in cell survival or death of various tissues in addition to the eye, how REP1 functions in normal and cancer cells remains to be elucidated. Here, we demonstrated that REP1 is required for the survival of intestinal cells in addition to eyes or a variety of cells in zebrafish, and also has important roles in tumorigenesis. Notably, REP1 is highly expressed in colon cancer tissues and cell lines, and silencing of REP1 sensitizes colon cancer cells to serum starvation- and 5-FU-induced apoptosis. In an effort to elucidate the molecular mechanisms underlying REP1-mediated cell survival under those stress conditions, we identified FOXO3 as a binding partner of REP1 using a yeast two-hybrid (Y2H) assay system, and we demonstrated that REP1 blocked the nuclear trans-localization of FOXO3 through physically interacting with FOXO3, thereby suppressing FOXO3-mediated apoptosis. Importantly, the inhibition of REP1 combined with 5-FU treatment could lead to significant retarded tumor growth in a xenograft tumor model of human cancer cells. Thus, our results suggest that REP1 could be a new therapeutic target in combination treatment for colon cancer patients.
Genes / Markers
Figures
Show all Figures
Expression
Phenotype
Mutations / Transgenics
Human Disease / Model
Sequence Targeting Reagents
Fish
Antibodies
Orthology
Engineered Foreign Genes
Mapping